Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

R Mina; A Belotti; MT Petrucci; R Zambello; A Capra; G Di Lullo; S Ronconi; N Pescosta; M Grasso; F Monaco; C Cellini; M Gobbi; S Ballanti; P de Fabritiis; ML Mosca-Siez; M Marchetti; AM Liberati; M Offidani; N Giuliani; R Ria; P Musto; A Romano; Pieter Sonneveld; M Boccadoro; A Larocca

doi:10.1038/s41408-020-0326-1

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

R Mina
, A Belotti
, MT Petrucci
, R Zambello
, A Capra
, G Di Lullo
, S Ronconi
, N Pescosta
, M Grasso
, F Monaco
, C Cellini
, M Gobbi
, S Ballanti
, P de Fabritiis
, ML Mosca-Siez
, M Marchetti
, AM Liberati
, M Offidani
, N Giuliani
, R Ria

P Musto, A Romano, Pieter Sonneveld, M Boccadoro, A Larocca

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

33 Downloads (Pure)

Original language	English
Article number	58
Journal	Blood Cancer Journal
Volume	10
Issue number	5
DOIs	https://doi.org/10.1038/s41408-020-0326-1
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1038/s41408-020-0326-1

Repub_127223_O-A.pdfFinal published version, 454 KB

Cite this

Mina, R., Belotti, A., Petrucci, MT., Zambello, R., Capra, A., Di Lullo, G., Ronconi, S., Pescosta, N., Grasso, M., Monaco, F., Cellini, C., Gobbi, M., Ballanti, S., de Fabritiis, P., Mosca-Siez, ML., Marchetti, M., Liberati, AM., Offidani, M., Giuliani, N., ... Larocca, A. (2020). Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. Blood Cancer Journal, 10(5), Article 58. https://doi.org/10.1038/s41408-020-0326-1

@article{aa1216485a334e988a42acf82c9f6154,

title = "Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study",

author = "R Mina and A Belotti and MT Petrucci and R Zambello and A Capra and \{Di Lullo\}, G and S Ronconi and N Pescosta and M Grasso and F Monaco and C Cellini and M Gobbi and S Ballanti and \{de Fabritiis\}, P and ML Mosca-Siez and M Marchetti and AM Liberati and M Offidani and N Giuliani and R Ria and P Musto and A Romano and Pieter Sonneveld and M Boccadoro and A Larocca",

year = "2020",

doi = "10.1038/s41408-020-0326-1",

language = "English",

volume = "10",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "5",

}

Mina, R, Belotti, A, Petrucci, MT, Zambello, R, Capra, A, Di Lullo, G, Ronconi, S, Pescosta, N, Grasso, M, Monaco, F, Cellini, C, Gobbi, M, Ballanti, S, de Fabritiis, P, Mosca-Siez, ML, Marchetti, M, Liberati, AM, Offidani, M, Giuliani, N, Ria, R, Musto, P, Romano, A, Sonneveld, P, Boccadoro, M & Larocca, A 2020, 'Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study', Blood Cancer Journal, vol. 10, no. 5, 58. https://doi.org/10.1038/s41408-020-0326-1

TY - JOUR

T1 - Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

AU - Mina, R

AU - Belotti, A

AU - Petrucci, MT

AU - Zambello, R

AU - Capra, A

AU - Di Lullo, G

AU - Ronconi, S

AU - Pescosta, N

AU - Grasso, M

AU - Monaco, F

AU - Cellini, C

AU - Gobbi, M

AU - Ballanti, S

AU - de Fabritiis, P

AU - Mosca-Siez, ML

AU - Marchetti, M

AU - Liberati, AM

AU - Offidani, M

AU - Giuliani, N

AU - Ria, R

AU - Musto, P

AU - Romano, A

AU - Sonneveld, Pieter

AU - Boccadoro, M

AU - Larocca, A

PY - 2020

Y1 - 2020

U2 - 10.1038/s41408-020-0326-1

DO - 10.1038/s41408-020-0326-1

M3 - Article

C2 - 32424154

SN - 2044-5385

VL - 10

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 5

M1 - 58

ER -